SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Samsung Biologics Rights Offering Was Oversubscribed

Samsung Biologics said its about KRW2.7T rights offering was oversubscribed last week.

207940

Related stories